Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution
Jupiter Neurosciences, Inc. (JUNS)
Company Research
Source: GlobeNewswire
Repayment Commencement Deferred to April 1, 2026 Core Economic Terms of $6.0 Million Financing Remain Unchanged JUPITER, FL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system disorders, today announced that it has entered into an Omnibus Amendment with YA II PN, Ltd. modifying the installment payment provisions of its previously disclosed Convertible Promissory Notes issued under the Company’s Standby Equity Purchase Agreement. Under the amendment: Monthly installment payments will now begin on April 1, 2026Principal repayments will follow a defined schedule agreed between the Company and Yorkville The amendment does not introduce any new pricing provisions, reset features or additional financing commitments. The amendment relates solely to installment timing and application mechanics and does not alter the underlying economic terms of the financing. “Thi
Show less
Read more
Impact Snapshot
Event Time:
JUNS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JUNS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JUNS alerts
High impacting Jupiter Neurosciences, Inc. news events
Weekly update
A roundup of the hottest topics
JUNS
News
- Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 UsersGlobeNewswire
- Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6 [Yahoo! Finance]Yahoo! Finance
- Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6GlobeNewswire
- $50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq [Yahoo! Finance]Yahoo! Finance
- Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial MomentumGlobeNewswire